Skip to main content

ASH | San Diego, CA | December 2016

By

ASH San Diego, CA | December 2016 Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV Efficacy of CD101, a Novel Echinocandin, in Mouse Models of Aspergillosis and Azole-Resistant Disseminated Candidiasis Efficacy of CD101, a Novel Echinocandin, in Prevention of Pneumocystis Pneumonia (PCP): Thwarting the Biphasic Life Cycle of Pneumocystis

Read More

ICHS-Infocus | Santiago, Chile | November 2016

By

ICHS-Infocus Santiago, Chile | November 2016 Subcutaneous (SC) Injection of CD101, a Novel Echinocandin: Efficacious, Well-Tolerated and Sustained Drug Exposures Safety and Pharmacokinetics of Single and Multiple Doses of CD101 IV: Results from Two Phase 1 Dose-Escalation Studies

Read More

IDWeek | New Orleans, LA | October 2016

By

IDWeek New Orleans, LA | October 2016 Activity of a Long-­Acting Echinocandin (CD101) and Comparator Antifungal Agents Tested Against Contemporary Worldwide Invasive Fungal Isolates PK-PD Target Attainment Analyses to Support the Selection of Extended-Interval CD101 Dosing Regimens

Read More

ACCP | Hollywood, FL | October 2016

By

ACCP Hollywood, FL | October 2016 Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters (encore) [261E] Safety and Pharmacokinetics of Single and Multiple Doses of CD101 IV: Results from Two Phase 1 Dose-Escalation Studies [258]

Read More

ASM Microbe | Boston, MA | June 2016

By

ASM Microbe Boston, MA | June 2016 Safety and Pharmacokinetics of Multiple Doses of CD101 Injection: Results from a Phase 1, Dose-escalation Study [LB-057] Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters [SUNDAY-505] Tissue Distribution and Pharmacokinetics of CD101 in an Immunocompetent Mouse Model of Invasive-Candidiasis [Presentation] Prevention of Pneumocystis Pneumonia by the Long Acting Echinocandin CD101 [Presentation] Efficacy of a Novel Echinocandin, CD101, in a Mouse Model of Azole-Resistant Disseminated Candidiasis [Presentation]

Read More

ECCMID | Amsterdam, Netherlands | April 2016

By

ECCMID Amsterdam, Netherlands | April 2016 The Safety and Single-Dose Pharmacokinetics of CD101 IV: Results From a Phase 1, Dose-Escalation Study [Presentation] Allometric Scaling and the Chimpanzee as a Surrogate for Human Pharmacokinetics of CD101, a Novel Echinocandin [P-1578]

Read More